Stellaromics Inc. · 8 hours ago
Systems Integration & Sustaining Engineer/Scientist 1
Stellaromics Inc. is an innovative biotech startup focused on enhancing biomedical research through their proprietary technology. The Systems Integration & Sustaining Engineer/Scientist I role involves ensuring the reliability of their spatial biology platform, providing systems integration, verification, and sustaining engineering support for commercial products.
3D TechnologyBiotechnology
Responsibilities
Develop, execute, and refine system-level integration and verification tests for automated imaging instruments, software, and assay workflows
Design test methods to evaluate instrument performance, assay robustness, and data quality, progressing toward independent test development within the first year
Perform system setup, configuration, calibration, and acceptance testing, including hands-on execution during early ramp
Support design verification and release testing for new features, assays, and system configurations
Independently verify design changes and fixes across complete workflows prior to release
Investigate, reproduce, and diagnose field and internal issues using production-equivalent systems
Perform root cause analysis across hardware, software, reagents, and user workflows, with coaching and increasing ownership over time
Analyze structured test and field data to identify trends, assess risk, and support technical decisions
Contribute to continuous improvement of system performance, reliability, and usability through data-driven insights
Create and maintain clear test documentation, issue tracking, and configuration records in compliance with quality systems
Collaborate cross-functionally with Engineering, Software, Assay Development, Service, Manufacturing, and Operations teams
Communicate test results, risks, and recommendations clearly to technical and cross-functional stakeholders
Support internal testing, pilot deployments, and controlled customer installations as needed
Qualification
Required
Bachelor's, master's, or PhD degree in bioengineering, systems engineering, chemistry, biology, or a related technical field
Bachelor's or master's degree with 3–5 years of relevant experience, or PhD with up to 1 year of post-graduate or industry experience
Demonstrated ability to design experiments or test methods and draw conclusions from data
Experience working with complex, multidisciplinary systems involving hardware, software, and biological workflows
Hands-on experience with laboratory instruments, automation platforms, or engineered systems
Ability to troubleshoot technical problems independently using structured problem-solving approaches
Working knowledge of wet lab techniques and assay workflows
Strong written and verbal communication skills for documenting results and collaborating across teams
Preferred
Familiarity with verification, sustaining engineering, or quality processes in a commercial or regulated environment is a plus
Experience analyzing experimental or test data using tools such as R, Python, MATLAB, or similar
Comfortable working in a fast-paced environment with evolving priorities and technical ambiguity
Benefits
Attractive compensation and benefits package based on market pay data
Significant opportunities for professional development and career advancement
Company
Stellaromics Inc.
Founded in 2022 and headquartered in Boston, Stellaromics is revolutionizing biomedical research with its proprietary technology, unraveling complex 3D transcription and translation patterns within native biological tissue.
H1B Sponsorship
Stellaromics Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (1)
2024 (1)
Funding
Current Stage
Growth StageTotal Funding
$105MKey Investors
Catalyst4Plaisance Capital Management
2025-02-11Series B· $80M
2023-11-02Series A· $25M
Recent News
Company data provided by crunchbase